AAPL343.37+3.29 (+0.97%) ▲|ABBV265.81+2.61 (+0.99%) ▲|ABT108.74+1.47 (+1.37%) ▲|ACN174.95+10.29 (+6.25%) ▲|ADBE264.54+15.36 (+6.16%) ▲|AMAT450.72-25.74 (-5.40%) ▼|AMD438.41-16.21 (-3.57%) ▼|AMGN389.84-3.26 (-0.83%) ▼|AMT173.52+2.02 (+1.18%) ▲|AMZN231.30+0.44 (+0.19%) ▲|AVGO377.12-3.80 (-1.00%) ▼|AXP333.13-3.51 (-1.04%) ▼|BA215.89-5.68 (-2.56%) ▼|BAC61.60-1.03 (-1.64%) ▼|BKNG204.03+4.72 (+2.37%) ▲|BLK1,098.17+0.62 (+0.06%) ▲|BMY63.67+0.07 (+0.10%) ▲|BNY153.55-2.95 (-1.88%) ▼|BRK-B510.63-1.75 (-0.34%) ▼|C127.65-4.83 (-3.64%) ▼|CAT781.26-59.60 (-7.09%) ▼|CL93.31+0.58 (+0.62%) ▲|CMCSA24.85+0.66 (+2.71%) ▲|COF210.38-2.03 (-0.96%) ▼|COP118.22+4.12 (+3.61%) ▲|COST974.80+8.22 (+0.85%) ▲|CRM189.06+7.56 (+4.17%) ▲|CSCO114.03-1.56 (-1.35%) ▼|CVS106.54-2.80 (-2.56%) ▼|CVX191.72+4.14 (+2.21%) ▲|DE614.72-25.13 (-3.93%) ▼|DHR198.11-0.94 (-0.47%) ▼|DIS98.89+0.00 (+0.00%) ▲|DUK129.38+0.14 (+0.11%) ▲|EMR146.87-4.94 (-3.25%) ▼|FDX309.34-3.31 (-1.06%) ▼|GD388.52-4.67 (-1.19%) ▼|GE353.79-9.80 (-2.70%) ▼|GEV906.96-36.42 (-3.86%) ▼|GILD134.43+0.11 (+0.08%) ▲|GM91.16+0.86 (+0.95%) ▲|GOOG338.98+6.38 (+1.92%) ▲|GOOGL339.83+6.12 (+1.83%) ▲|GS991.09-42.25 (-4.09%) ▼|HD340.69-3.78 (-1.10%) ▼|HON243.80-3.26 (-1.32%) ▼|IBM228.83+1.28 (+0.56%) ▲|INTC83.98-2.32 (-2.69%) ▼|INTU335.65+22.66 (+7.24%) ▲|ISRG354.36-7.44 (-2.06%) ▼|JNJ266.31-0.42 (-0.16%) ▼|JPM347.40-9.92 (-2.77%) ▼|KO89.12+0.85 (+0.96%) ▲|LIN511.51+0.33 (+0.06%) ▲|LLY1,218.56-2.11 (-0.17%) ▼|LMT576.19-5.12 (-0.88%) ▼|LOW217.71-0.53 (-0.24%) ▼|LRCX258.45-11.16 (-4.14%) ▼|MA566.34+3.59 (+0.64%) ▲|MCD272.04-0.99 (-0.36%) ▼|MDLZ65.20+2.72 (+4.35%) ▲|MDT87.62+0.74 (+0.85%) ▲|META593.40-0.02 (0.00%) ▼|MMM179.43-3.05 (-1.67%) ▼|MO75.17+0.35 (+0.47%) ▲|MRK131.08-0.74 (-0.56%) ▼|MS204.67-6.91 (-3.27%) ▼|MSFT398.10+4.75 (+1.21%) ▲|MU763.76-56.78 (-6.92%) ▼|NEE88.83-0.45 (-0.50%) ▼|NFLX73.58+1.19 (+1.64%) ▲|NKE43.17+0.12 (+0.27%) ▲|NOW116.38+5.76 (+5.21%) ▲|NVDA192.84-4.17 (-2.12%) ▼|ORCL119.28-0.69 (-0.57%) ▼|PEP144.34+1.48 (+1.04%) ▲|PFE25.20-0.06 (-0.22%) ▼|PG145.07-3.82 (-2.56%) ▼|PLTR125.19+1.66 (+1.34%) ▲|PM199.72-0.46 (-0.23%) ▼|QCOM160.70-2.19 (-1.34%) ▼|RTX218.92+0.34 (+0.16%) ▲|SBUX104.02+0.92 (+0.89%) ▲|SCHW105.62-0.35 (-0.33%) ▼|SO96.21-0.57 (-0.59%) ▼|SPG237.38+0.68 (+0.29%) ▲|T24.33-0.34 (-1.36%) ▼|TMO571.53-4.88 (-0.85%) ▼|TMUS182.00-0.39 (-0.21%) ▼|TSLA302.43-5.01 (-1.63%) ▼|TXN275.59-1.49 (-0.54%) ▼|UBER71.36+0.62 (+0.88%) ▲|UNH421.63-7.16 (-1.67%) ▼|UNP291.27-3.18 (-1.08%) ▼|UPS104.26-1.28 (-1.21%) ▼|USB63.17-1.26 (-1.96%) ▼|V368.81+2.22 (+0.61%) ▲|VZ48.40+0.21 (+0.43%) ▲|WFC84.44-2.43 (-2.80%) ▼|WMT114.08+0.98 (+0.87%) ▲|XOM156.55+3.51 (+2.29%) ▲|AAPL343.37+3.29 (+0.97%) ▲|ABBV265.81+2.61 (+0.99%) ▲|ABT108.74+1.47 (+1.37%) ▲|ACN174.95+10.29 (+6.25%) ▲|ADBE264.54+15.36 (+6.16%) ▲|AMAT450.72-25.74 (-5.40%) ▼|AMD438.41-16.21 (-3.57%) ▼|AMGN389.84-3.26 (-0.83%) ▼|AMT173.52+2.02 (+1.18%) ▲|AMZN231.30+0.44 (+0.19%) ▲|AVGO377.12-3.80 (-1.00%) ▼|AXP333.13-3.51 (-1.04%) ▼|BA215.89-5.68 (-2.56%) ▼|BAC61.60-1.03 (-1.64%) ▼|BKNG204.03+4.72 (+2.37%) ▲|BLK1,098.17+0.62 (+0.06%) ▲|BMY63.67+0.07 (+0.10%) ▲|BNY153.55-2.95 (-1.88%) ▼|BRK-B510.63-1.75 (-0.34%) ▼|C127.65-4.83 (-3.64%) ▼|CAT781.26-59.60 (-7.09%) ▼|CL93.31+0.58 (+0.62%) ▲|CMCSA24.85+0.66 (+2.71%) ▲|COF210.38-2.03 (-0.96%) ▼|COP118.22+4.12 (+3.61%) ▲|COST974.80+8.22 (+0.85%) ▲|CRM189.06+7.56 (+4.17%) ▲|CSCO114.03-1.56 (-1.35%) ▼|CVS106.54-2.80 (-2.56%) ▼|CVX191.72+4.14 (+2.21%) ▲|DE614.72-25.13 (-3.93%) ▼|DHR198.11-0.94 (-0.47%) ▼|DIS98.89+0.00 (+0.00%) ▲|DUK129.38+0.14 (+0.11%) ▲|EMR146.87-4.94 (-3.25%) ▼|FDX309.34-3.31 (-1.06%) ▼|GD388.52-4.67 (-1.19%) ▼|GE353.79-9.80 (-2.70%) ▼|GEV906.96-36.42 (-3.86%) ▼|GILD134.43+0.11 (+0.08%) ▲|GM91.16+0.86 (+0.95%) ▲|GOOG338.98+6.38 (+1.92%) ▲|GOOGL339.83+6.12 (+1.83%) ▲|GS991.09-42.25 (-4.09%) ▼|HD340.69-3.78 (-1.10%) ▼|HON243.80-3.26 (-1.32%) ▼|IBM228.83+1.28 (+0.56%) ▲|INTC83.98-2.32 (-2.69%) ▼|INTU335.65+22.66 (+7.24%) ▲|ISRG354.36-7.44 (-2.06%) ▼|JNJ266.31-0.42 (-0.16%) ▼|JPM347.40-9.92 (-2.77%) ▼|KO89.12+0.85 (+0.96%) ▲|LIN511.51+0.33 (+0.06%) ▲|LLY1,218.56-2.11 (-0.17%) ▼|LMT576.19-5.12 (-0.88%) ▼|LOW217.71-0.53 (-0.24%) ▼|LRCX258.45-11.16 (-4.14%) ▼|MA566.34+3.59 (+0.64%) ▲|MCD272.04-0.99 (-0.36%) ▼|MDLZ65.20+2.72 (+4.35%) ▲|MDT87.62+0.74 (+0.85%) ▲|META593.40-0.02 (0.00%) ▼|MMM179.43-3.05 (-1.67%) ▼|MO75.17+0.35 (+0.47%) ▲|MRK131.08-0.74 (-0.56%) ▼|MS204.67-6.91 (-3.27%) ▼|MSFT398.10+4.75 (+1.21%) ▲|MU763.76-56.78 (-6.92%) ▼|NEE88.83-0.45 (-0.50%) ▼|NFLX73.58+1.19 (+1.64%) ▲|NKE43.17+0.12 (+0.27%) ▲|NOW116.38+5.76 (+5.21%) ▲|NVDA192.84-4.17 (-2.12%) ▼|ORCL119.28-0.69 (-0.57%) ▼|PEP144.34+1.48 (+1.04%) ▲|PFE25.20-0.06 (-0.22%) ▼|PG145.07-3.82 (-2.56%) ▼|PLTR125.19+1.66 (+1.34%) ▲|PM199.72-0.46 (-0.23%) ▼|QCOM160.70-2.19 (-1.34%) ▼|RTX218.92+0.34 (+0.16%) ▲|SBUX104.02+0.92 (+0.89%) ▲|SCHW105.62-0.35 (-0.33%) ▼|SO96.21-0.57 (-0.59%) ▼|SPG237.38+0.68 (+0.29%) ▲|T24.33-0.34 (-1.36%) ▼|TMO571.53-4.88 (-0.85%) ▼|TMUS182.00-0.39 (-0.21%) ▼|TSLA302.43-5.01 (-1.63%) ▼|TXN275.59-1.49 (-0.54%) ▼|UBER71.36+0.62 (+0.88%) ▲|UNH421.63-7.16 (-1.67%) ▼|UNP291.27-3.18 (-1.08%) ▼|UPS104.26-1.28 (-1.21%) ▼|USB63.17-1.26 (-1.96%) ▼|V368.81+2.22 (+0.61%) ▲|VZ48.40+0.21 (+0.43%) ▲|WFC84.44-2.43 (-2.80%) ▼|WMT114.08+0.98 (+0.87%) ▲|XOM156.55+3.51 (+2.29%) ▲|
26.8 C
New York
Wednesday, July 29, 2026

Tag: immune system

newssourceFORcompanyinformationcontent1releasesmarket

Tumor-Infiltrating Lymphocyte Therapy Market Gains Momentum with Expanding Oncology Applications | DelveInsight

Over the last ten years, cell-based immunotherapy has emerged as a promising approach for treating solid tumors. Several companies, including Iovance Biotherapeutics, Obsidian Therapeutics,...

Tumor-Infiltrating Lymphocyte Therapy Market Gains Momentum with Expanding Oncology Applications | DelveInsight

Over the last ten years, cell-based immunotherapy has emerged as a promising approach for treating solid tumors. Several companies, including Iovance Biotherapeutics, Obsidian Therapeutics,...

5 Pew-Stewart Scholars Selected to Pursue Pioneering Cancer Research

PHILADELPHIA, Aug. 12, 2025 /PRNewswire/ -- The Pew Charitable Trusts and the Alexander and Margaret Stewart Trust announced today the 2025 class of the...

Anixa Biosciences Announces Issuance of Additional U.S. Patent for CAR-T Technology

Newly issued patent extends protection of proprietary solid tumor CAR-T platform to 2045 SAN JOSE, Calif., Aug. 12, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa"...

Novartis ianalumab Phase III trial meets primary endpoint in ITP, demonstrating statistically significant improvement in time to treatment failure

Booking Health Unveils New Study: Role of Immunotherapy in Extending Life Expectancy for Stage4 Cervical Cancer Patients

Langenfeld, Germany, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Booking Health, a global leader in medical treatment coordination, today unveiled a new study titled Role of Immunotherapy in Extending Life Expectancy for Stage 4 Cervical Cancer Patients. The report outlines how cutting-edge immunotherapy is reshaping care for women with advanced cervical cancer, offering new pathways to longer survival and improved quality of life, particularly in cases resistant to standard treatments.

Evaxion to announce business update and second quarter 2025 financial results on August 14, 2025

COPENHAGEN, Denmark, August 11, 2025 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, will provide a business update and report its second quarter 2025 financial results on Thursday August 14, 2025, before opening of the Nasdaq CM.

Edesa Biotech Reports Fiscal 3rd Quarter 2025 Results

TORONTO, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, today reported financial results for the three and nine months ended June 30, 2025 and provided an update on its business.

Anixa Biosciences Announces Dr. Robert Wenham will speak about Immunotherapy in surviving Ovarian Cancer at the 13th Annual Ovarcoming Cancer Conference

Dr. Wenham is Principal investigator on Anixa's CAR-T therapy for Ovarian Cancer SAN JOSE, Calif., Aug. 8, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or...

Lilly reports second-quarter 2025 financial results and raises guidance

Revenue in Q2 2025 increased 38% to $15.56 billion driven by volume growth from Zepbound and Mounjaro. Increased the midpoint of our 2025 full-year...

Press Release: Sanofi completes the acquisition of Vigil Neuroscience, Inc.

Sanofi completes the acquisition of Vigil Neuroscience, Inc.

Vitiligo Market to Register Incremental Growth at a CAGR of 9.6% During the Forecast Period (2025-2034) | DelveInsight

The vitiligo market is witnessing steady growth due to rising disease awareness, improved diagnostic capabilities, and advancements in treatment options such as JAK inhibitors...

CancerVax Successfully Disguises Cancer Cells and Tricks Immune Cells into Attacking Them

Recent lab results proved the Company’s hypothesis that disguising cancer cells to look like common infectious diseases can trick immune cells into attacking the malignant cells 
Recent lab results proved the Company’s hypothesis that disguising cancer cells to look like common infectious diseases can trick immune cells into attacking the malignant cells

Kuros Biosciences launches MagnetOs MIS Delivery System by completing first cases, and continues global expansion with incremental Brazil clearance

   
Kuros Biosciences launches MagnetOs MIS Delivery System by completing first cases, and continues global expansion with incremental Brazil clearance

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsImmune system

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers